MedTrace Logo

Immunopathogenesis of Chlamydia

NCT00607659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2016-04-14

No results posted yet for this study

Summary

Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factors for adverse outcomes following genital tract infection with Chlamydia trachomatis and to evaluate whether or not the presence of C. trachomatis in the rectum act as a reservoir for infection.

Conditions

  • CHLAMYDIA INFECTIONS

Interventions

OTHER

No intervention, only observational

No intervention, only observational

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • Amy M Scurlock, M.D. · Arkansas Children's Hospital Research Institute

Eligibility

Min Age
11 Years
Max Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00607659 on ClinicalTrials.gov